Arecor

Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseases

Little Chesterford, United KingdomFounded 2007arecor.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Arecor

Arecor is a clinical-stage biotechnology company developing therapeutics for diabetes, obesity and other cardiometabolic diseases. Its portfolio includes AT278, an ultra-concentrated, ultra-rapid-acting insulin, and a drug delivery platform in development for oral peptides.

The company partners with pharmaceutical, biotechnology and medical technology companies, generating revenue from partnerships and technology licensing. It has a co-development agreement with Sequel Med Tech for preparatory work on a Phase 2 trial combining AT278 with an insulin pump.

Arecor was founded in 2007 and is headquartered in Little Chesterford, where it has an office and laboratory.

Product: Therapeutic candidates and the Arestat drug formulation technology platform, including AT278 insulin and oral peptide delivery development.

Jobs at Arecor

No open positions listed right now.

More biotech & pharma companies

  • Aspire Pharma

    Specialty and niche generic medicines for patients, healthcare professionals and health systems in the UK and international markets
    Godalming, United KingdomBiotech & pharmaFounded 20093 open jobs
    New on EvolcRemote-friendly
  • Astute Healthcare

    Wholesale distributor of medicines and FMCG health and personal care products to pharmacies, retailers and hospitals in the UK
    Hitchin, United KingdomBiotech & pharmaFounded 20129 open jobs
    New on Evolc
  • Autolus

    Develops engineered T-cell therapies for patients with cancer and autoimmune diseases
    London, United KingdomBiotech & pharmaFounded 201415 open jobs
    New on EvolcRemote-friendly
  • Automata

    Lab automation hardware and software for life science labs, including workflow orchestration and configurable lab benches
    United KingdomBiotech & pharma5 open jobs
    New on EvolcRemote-friendly
  • Avacta Life Sciences

    Clinical-stage biopharma developing tumor-activated peptide drug conjugates that release cancer drugs only in tumors
    London, United KingdomBiotech & pharmaFounded 2008
    New on Evolc
  • Avaxmed

    Develops solid-dose vaccine and medication manufacturing and needle-free delivery technology for human and veterinary use
    Abingdon, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Google Analytics 4
  • WordPress
  • jQuery